| | Group A | Group B |
| IIEF-15, mean ± SD | 11.54 ± 2.47a,b | 1.32 ± 2.67 | IIEF-EF, mean ± SD | 0.35 ± 1.42 | 0.04 ± 1.00 | IIEF-IS, mean ± SD | 1.72 ± 1.63a,b | 0.05 ± 2.15 | IIEF-OF, mean ± SD | 2.20 ± 1.51a,b | 0.08 ± 1.77 | IIEF-SD, mean ± SD | 1.03 ± 1.35a,b | 0.41 ± 0.34 | IIEF-OS, mean ± SD | 2.51 ± 1.45a,b | 0.57 ± 0.39 | MSHQ-EjD, mean ± SD | 1.21 ± 2.03a,b | 0.24 ± 1.07 | SQoL-M, mean ± SD | 10.20 ± 3.77a,b | 1.24 ± 2.53 | PSV (cm/s), mean ± SD | 1.36 ± 0.75a,b | 0.21 ± 0.44 | EDV (cm/s), mean ± SD | 0.24 ± 1.0 | 0.31 ± 0.9 | Total testosterone (nmol/L), mean ± SD | 14.26 ± 2.05 | 13.31 ± 1.32 | Normal arterial function (PSV ≥35 cm/s) subgroup | | | IIEF-EF, mean ± SD | 0.94 ± 3.68 | 0.10 ± 4.10 | PSV (cm/s), mean ± SD | 0.16 ± 0.75 | 0.10 ± 0.87 | MSHQ-EJD, mean ± SD | 1.41 ± 1.85a,b | 0.32 ± 1.54 | SQoL-M, mean ± SD | 8.76 ± 3.65 | 1.41 ± 3.21 | Moderate arterial dysfunction (PSV ≥25 and <35 cm/s) subgroup | | | IIEF-EF, mean ± SD | 1.82 ± 3.08a,b | 0.16 ± 2.69 | PSV (cm/s), mean ± SD | 1.56 ± 0.82a,b | 0.23 ± 0.63 | MSHQ-EJD, mean ± SD | 1.23 ± 1.84a,b | 0.11 ± 1.52 | SQoL-M, mean ± SD | 11.65 ± 3.12a,b | 1.18 ± 2.87 | Severe arterial dysfunction (PSV <25 cm/s) subgroup | | | IIEF-EF, mean ± SD | 0.54 ± 2.77 | 0.23 ± 2.41 | PSV (cm/s), mean ± SD | 0.05 ± 0.52 | 0.09 ± 0.74 | MSHQ-EJD, mean ± SD | 0.90 ± 2.56 | 0.25 ± 2.31 | SQoL-M, mean ± SD | 2.43 ± 2.89 | 1.21 ± 3.44 |
|
|